Software to Simplify 21 CFR Part 11 Compliance in Pharma Industry
Ensuring the safety, efficacy, and quality of products is critical in any industry, but more so in pharma due to its direct impact on the health and life of its users. Therefore, it is highly regulated, and 21 CFR Part 11 stands out as a critical guideline for managing electronic records and electronic signatures.
The US Food and Drug Administration (FDA) introduced regulation as companies adopted digital systems, replacing traditional paper-based record-keeping. The regulation is a set of FDA guidelines defining the criteria for electronic records and electronic signatures to be considered equivalent to paper records and handwritten signatures. It ensures the authenticity, integrity, and confidentiality of electronic records.